IRIS Accounts Production v24.2.0.383 14493628 Board of Directors 18.11.22 5.4.24 5.4.24 false true false false true false Ordinary 1.00000 Ordinary A 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh144936282022-11-17144936282024-04-05144936282022-11-182024-04-05144936282022-11-1714493628ns15:EnglandWales2022-11-182024-04-0514493628ns14:PoundSterling2022-11-182024-04-0514493628ns10:Director12022-11-182024-04-0514493628ns10:PrivateLimitedCompanyLtd2022-11-182024-04-0514493628ns10:SmallEntities2022-11-182024-04-0514493628ns10:AuditExempt-NoAccountantsReport2022-11-182024-04-0514493628ns10:SmallCompaniesRegimeForDirectorsReport2022-11-182024-04-0514493628ns10:SmallCompaniesRegimeForAccounts2022-11-182024-04-0514493628ns10:FullAccounts2022-11-182024-04-0514493628ns10:OrdinaryShareClass12022-11-182024-04-0514493628ns10:OrdinaryShareClass22022-11-182024-04-0514493628ns5:CurrentFinancialInstruments2024-04-0514493628ns5:ShareCapital2024-04-0514493628ns5:RetainedEarningsAccumulatedLosses2024-04-0514493628ns10:RegisteredOffice2022-11-182024-04-0514493628ns5:PlantMachinery2022-11-182024-04-0514493628ns5:PlantMachinery2024-04-0514493628ns5:WithinOneYearns5:CurrentFinancialInstruments2024-04-0514493628ns10:OrdinaryShareClass12024-04-0514493628ns10:OrdinaryShareClass22024-04-05
REGISTERED NUMBER: 14493628 (England and Wales)










MBP MEDICAL CONSULTING LTD

UNAUDITED FINANCIAL STATEMENTS

FOR THE PERIOD 18TH NOVEMBER 2022 TO 5TH APRIL 2024






MBP MEDICAL CONSULTING LTD (REGISTERED NUMBER: 14493628)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE PERIOD 18TH NOVEMBER 2022 TO 5TH APRIL 2024










Page

Balance Sheet 1

Notes to the Financial Statements 2 to 4


MBP MEDICAL CONSULTING LTD (REGISTERED NUMBER: 14493628)

BALANCE SHEET
5TH APRIL 2024

Notes £    £   
FIXED ASSETS
Tangible assets 4 7,601

CURRENT ASSETS
Debtors 5 953
Cash at bank 11,448
12,401
CREDITORS
Amounts falling due within one year 6 5,513
NET CURRENT ASSETS 6,888
TOTAL ASSETS LESS CURRENT LIABILITIES 14,489

PROVISIONS FOR LIABILITIES 1,444
NET ASSETS 13,045

CAPITAL AND RESERVES
Called up share capital 7 2
Retained earnings 13,043
SHAREHOLDERS' FUNDS 13,045

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 5th April 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 5th April 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 9th August 2024 and were signed on its behalf by:





M Perkins - Director


MBP MEDICAL CONSULTING LTD (REGISTERED NUMBER: 14493628)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD 18TH NOVEMBER 2022 TO 5TH APRIL 2024


1. STATUTORY INFORMATION

MBP Medical Consulting Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 14493628

Registered office: 2 Park Corner Fold
Scriven
Knaresborough
HG5 9EF

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements are presented in sterling which is the functional currency of the company and rounded to the nearest £.

The significant accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all years presented unless otherwise stated.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Tangible fixed assets are stated at cost (or deemed cost) or valuation less accumulated depreciation and accumulated impairment losses. Cost includes costs directly attributable to making the asset capable of operating as intended.

Depreciation is provided on all tangible fixed assets, at rates calculated to write off the cost, less estimated residual value, of each asset on a systematic basis over its expected useful life as follows:

Computer Equipment - 25% Straight line
Fixtures & Fittings - 25% Straight line

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


MBP MEDICAL CONSULTING LTD (REGISTERED NUMBER: 14493628)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 18TH NOVEMBER 2022 TO 5TH APRIL 2024


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Debtors and creditors
Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price.

Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 2 .

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
Additions 7,804
At 5th April 2024 7,804
DEPRECIATION
Charge for period 203
At 5th April 2024 203
NET BOOK VALUE
At 5th April 2024 7,601

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Other debtors 953

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Taxation and social security 1,615
Other creditors 3,898
5,513

MBP MEDICAL CONSULTING LTD (REGISTERED NUMBER: 14493628)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 18TH NOVEMBER 2022 TO 5TH APRIL 2024


7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal
value: £   
1 Ordinary £1 1
1 Ordinary A £1 1
2

8. RELATED PARTY DISCLOSURES

Included in other creditors are amounts owed to the directors of £2,937.